About 3 results found for searched term "Ralaniten" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10960 | Ralaniten | Androgen Receptor |
| EPI-002 | ||
| Ralaniten (EPI-002) is an effective and orally active androgen receptor N-terminal domain (AR-NTD) antagonist. Ralaniten inhibits AR transcriptional activity,IC50 The value is 7.4 μM. Ralanites can be used in the study of castration-resistant prostate cancer (CRPC). | ||
| M10961 | Ralaniten triacetate | Androgen Receptor |
| EPI-506 | ||
| Ralaniten triacetate (EPI-506), a prodrug for Ralaniten, is a pioneering, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate is active against full-length and resistance-related AR species, including AR-v7. | ||
| M29293 | EPI-7170 | Androgen Receptor |
| EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
